Insider · CIK 0000889131

ROCHE HOLDING LTD

Reports to the SEC for 10 companies · BASEL, V8

sec.gov

Transactions

Companies

Filings

CIK

0000889131

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-25	JSPRJasper Therapeutics, Inc.S Sale	10% Owner	SSale	−75K sh	$1.89	−$142K	4,549,606
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−318K sh	—	—	0
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.5M sh	—	—	2,495,385
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	10% Owner	CConversion	+318K sh	—	—	2,813,525
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−2.5M sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+36.1K sh	$18.00	+$650K	3,086,084
2020-07-21	Pandion Therapeutics, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−13.1M sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−2.41M sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.05M sh	—	—	3,049,973
2018-07-23	Allakos Inc.Series A Preferrred StockC Conversion	10% Owner	CConversion	−4.11M sh	—	—	0
2018-07-23	Allakos Inc.C Conversion	10% Owner	CConversion	+4.61M sh	—	—	4,610,723
2018-07-23	Allakos Inc.Series B Preferrred StockC Conversion	10% Owner	CConversion	−503K sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc.C Conversion	10% Owner	CConversion	+579K sh	—	—	582,963
2017-07-05	RNTXRein Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+119K sh	$15.00	+$1.79M	702,363
2017-07-05	RNTXRein Therapeutics, Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−3.39M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series E-2 Preferred StockC Conversion	10% Owner	CConversion	−736K sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series E-3 Preferred StockC Conversion	10% Owner	CConversion	−638K sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series F Preferred StockC Conversion	10% Owner	CConversion	−990K sh	—	—	0
2007-06-26	BIOVERIS CORPP Purchase	100% Owner	PPurchase	+1,000 sh	$21.50	+$21.5K	1,000
2007-06-26	BIOVERIS CORPP Purchase	100% Owner	PPurchase	+1,000 sh	—	—	1,000

Recent filings

Accepted (ET)
Jan 264
ROCHE HOLDING LTD0001104659-23-007094
SEC(opens sec.gov)
Nov 44
ROCHE HOLDING LTD0001104659-21-134647
SEC(opens sec.gov)
Jul 234
ROCHE HOLDING LTD0000899243-20-020217
SEC(opens sec.gov)
Jul 234
ROCHE HOLDING LTD0001209191-18-043630
SEC(opens sec.gov)
Jul 54
AILERON THERAPEUTICS INC0000899243-17-017896
SEC(opens sec.gov)
Jul 64
BIOVERIS CORP0000950103-07-001741
SEC(opens sec.gov)

Companies

Address

GRENZACHERSTRASSE 124

BASEL, V8, CH-4070